{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T15:07:37Z","timestamp":1777388857535,"version":"3.51.4"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,4,3]],"date-time":"2019-04-03T00:00:00Z","timestamp":1554249600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100004339","name":"Sanofi","doi-asserted-by":"publisher","award":["DIREGC07005"],"award-info":[{"award-number":["DIREGC07005"]}],"id":[{"id":"10.13039\/100004339","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Orphanet J Rare Dis"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1186\/s13023-019-1054-0","type":"journal-article","created":{"date-parts":[[2019,4,3]],"date-time":"2019-04-03T13:03:02Z","timestamp":1554296582000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["Characteristics of Pompe disease in China: a report from the Pompe registry"],"prefix":"10.1186","volume":"14","author":[{"given":"Yuying","family":"Zhao","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhaoxia","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiahong","family":"Lu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xuefan","family":"Gu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yonglan","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhengqing","family":"Qiu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yanping","family":"Wei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chuanzhu","family":"Yan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,4,3]]},"reference":[{"key":"1054_CR1","first-page":"82","volume":"32","author":"F Manganelli","year":"2013","unstructured":"Manganelli F, Ruggiero L. Clinical features of Pompe disease. Acta Myol. 2013;32:82\u20134.","journal-title":"Acta Myol"},{"key":"1054_CR2","first-page":"3389","volume":"3","author":"R Hirschhorn","year":"2001","unstructured":"Hirschhorn R, Reuser AJ. Glycogen storage disease type II: acid alpha-glucosidase (acid maltase) deficiency. The metabolic and molecular bases of inherited disease. 2001;3:3389\u2013420.","journal-title":"The metabolic and molecular bases of inherited disease"},{"key":"1054_CR3","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1097\/01.gim.0000218152.87434.f3","volume":"8","author":"PS Kishnani","year":"2006","unstructured":"Kishnani PS, Steiner RD, Bali D, Berger K, Byrne BJ, Case LE, Crowley JF, Downs S, Howell RR, Kravitz RM, et al. Pompe disease diagnosis and management guideline. Genet Med. 2006;8:267\u201388.","journal-title":"Genet Med"},{"key":"1054_CR4","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1038\/sj.ejhg.5200367","volume":"7","author":"MG Ausems","year":"1999","unstructured":"Ausems MG, Verbiest J, Hermans MP, Kroos MA, Beemer FA, Wokke JH, Sandkuijl LA, Reuser AJ, van der Ploeg AT. Frequency of glycogen storage disease type II in The Netherlands: implications for diagnosis and genetic counselling. Eur J Hum Genet. 1999;7:713\u20136.","journal-title":"Eur J Hum Genet"},{"key":"1054_CR5","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1002\/(SICI)1096-8628(19980827)79:1<69::AID-AJMG16>3.0.CO;2-K","volume":"79","author":"F Martiniuk","year":"1998","unstructured":"Martiniuk F, Chen A, Mack A, Arvanitopoulos E, Chen Y, Rom WN, Codd WJ, Hanna B, Alcabes P, Raben N, Plotz P. Carrier frequency for glycogen storage disease type II in New York and estimates of affected individuals born with the disease. Am J Med Genet. 1998;79:69\u201372.","journal-title":"Am J Med Genet"},{"key":"1054_CR6","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1016\/S0140-6736(11)61266-X","volume":"379","author":"TP Mechtler","year":"2012","unstructured":"Mechtler TP, Stary S, Metz TF, De Jesus VR, Greber-Platzer S, Pollak A, Herkner KR, Streubel B, Kasper DC. Neonatal screening for lysosomal storage disorders: feasibility and incidence from a nationwide study in Austria. Lancet. 2012;379:335\u201341.","journal-title":"Lancet"},{"key":"1054_CR7","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1016\/j.ymgme.2012.04.013","volume":"106","author":"SC Chiang","year":"2012","unstructured":"Chiang SC, Hwu WL, Lee NC, Hsu LW, Chien YH. Algorithm for Pompe disease newborn screening: results from the Taiwan screening program. Mol Genet Metab. 2012;106:281\u20136.","journal-title":"Mol Genet Metab"},{"key":"1054_CR8","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1016\/j.ncl.2014.04.010","volume":"32","author":"M Dasouki","year":"2014","unstructured":"Dasouki M, Jawdat O, Almadhoun O, Pasnoor M, McVey AL, Abuzinadah A, Herbelin L, Barohn RJ, Dimachkie MM. Pompe disease: literature review and case series. Neurol Clin. 2014;32:751\u201376 ix.","journal-title":"Neurol Clin"},{"key":"1054_CR9","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1007\/978-90-481-2813-6_4","volume":"652","author":"SI Pascual","year":"2009","unstructured":"Pascual SI. Phenotype variations in early onset Pompe disease: diagnosis and treatment results with Myozyme. Adv Exp Med Biol. 2009;652:39\u201346.","journal-title":"Adv Exp Med Biol"},{"key":"1054_CR10","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1016\/j.jpeds.2005.11.033","volume":"148","author":"PS Kishnani","year":"2006","unstructured":"Kishnani PS, Hwu WL, Mandel H, Nicolino M, Yong F, Corzo D. A retrospective, multinational, multicenter study on the natural history of infantile-onset Pompe disease. J Pediatr. 2006;148:671\u20136.","journal-title":"J Pediatr"},{"key":"1054_CR11","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1542\/peds.112.2.332","volume":"112","author":"HM Hout van den","year":"2003","unstructured":"van den Hout HM, Hop W, van Diggelen OP, Smeitink JA, Smit GP, Poll-The BT, Bakker HD, Loonen MC, de Klerk JB, Reuser AJ, van der Ploeg AT. The natural course of infantile Pompe's disease: 20 original cases compared with 133 cases from the literature. Pediatrics. 2003;112:332\u201340.","journal-title":"Pediatrics"},{"key":"1054_CR12","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1007\/s00415-005-0922-9","volume":"252","author":"LP Winkel","year":"2005","unstructured":"Winkel LP, Hagemans ML, van Doorn PA, Loonen MC, Hop WJ, Reuser AJ, van der Ploeg AT. The natural course of non-classic Pompe's disease; a review of 225 published cases. J Neurol. 2005;252:875\u201384.","journal-title":"J Neurol"},{"key":"1054_CR13","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.gene.2013.10.066","volume":"535","author":"L Fu","year":"2014","unstructured":"Fu L, Qiu W, Yu Y, Guo Y, Zhao P, Zhang X, Liu C, Li F, Huang H, Huang M, Chen S. Clinical and molecular genetic study of infantile-onset Pompe disease in Chinese patients: identification of 6 novel mutations. Gene. 2014;535:53\u20139.","journal-title":"Gene"},{"key":"1054_CR14","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1093\/eurheartj\/ehu454","volume":"36","author":"J Hu","year":"2015","unstructured":"Hu J, Sun L, Ren W, Xu M. Two novel mutations in the gene that codes for acid alpha-glucosidase in a baby with Pompe disease. Eur Heart J. 2015;36:883.","journal-title":"Eur Heart J"},{"key":"1054_CR15","doi-asserted-by":"publisher","first-page":"713","DOI":"10.2147\/NDT.S94892","volume":"12","author":"B Zhang","year":"2016","unstructured":"Zhang B, Zhao Y, Liu J, Li L, Shan J, Zhao D, Yan C. Late-onset Pompe disease with complicated intracranial aneurysm: a Chinese case report. Neuropsychiatr Dis Treat. 2016;12:713\u20137.","journal-title":"Neuropsychiatr Dis Treat"},{"key":"1054_CR16","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1186\/s12881-014-0141-2","volume":"15","author":"X Liu","year":"2014","unstructured":"Liu X, Wang Z, Jin W, Lv H, Zhang W, Que C, Huang Y, Yuan Y. Clinical and GAA gene mutation analysis in mainland Chinese patients with late-onset Pompe disease: identifying c.2238G > C as the most common mutation. BMC Med Genet. 2014;15:141.","journal-title":"BMC Med Genet"},{"key":"1054_CR17","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1016\/j.ymgme.2011.06.010","volume":"104","author":"CC Yang","year":"2011","unstructured":"Yang CC, Chien YH, Lee NC, Chiang SC, Lin SP, Kuo YT, Chen SS, Jong YJ, Hwu WL. Rapid progressive course of later-onset Pompe disease in Chinese patients. Mol Genet Metab. 2011;104:284\u20138.","journal-title":"Mol Genet Metab"},{"key":"1054_CR18","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ymgme.2011.02.004","volume":"103","author":"BJ Byrne","year":"2011","unstructured":"Byrne BJ, Kishnani PS, Case LE, Merlini L, Muller-Felber W, Prasad S, van der Ploeg A. Pompe disease: design, methodology, and early findings from the Pompe registry. Mol Genet Metab. 2011;103:1\u201311.","journal-title":"Mol Genet Metab"},{"key":"1054_CR19","doi-asserted-by":"publisher","first-page":"2139","DOI":"10.1212\/01.WNL.0000165979.46537.56","volume":"64","author":"ML Hagemans","year":"2005","unstructured":"Hagemans ML, Winkel LP, Hop WC, Reuser AJ, Van Doorn PA, Van der Ploeg AT. Disease severity in children and adults with Pompe disease related to age and disease duration. Neurology. 2005;64:2139\u201341.","journal-title":"Neurology"},{"key":"1054_CR20","doi-asserted-by":"publisher","first-page":"1396","DOI":"10.1056\/NEJMoa0909859","volume":"362","author":"AT Ploeg van der","year":"2010","unstructured":"van der Ploeg AT, Clemens PR, Corzo D, Escolar DM, Florence J, Groeneveld GJ, Herson S, Kishnani PS, Laforet P, Lake SL, et al. A randomized study of alglucosidase alfa in late-onset Pompe's disease. N Engl J Med. 2010;362:1396\u2013406.","journal-title":"N Engl J Med"},{"key":"1054_CR21","doi-asserted-by":"publisher","unstructured":"American Association OF Neuromuscular & Electrodiagnostic Medicine. Diagnostic criteria for late-onset (childhood and adult) Pompe disease. Muscle Nerve. 2009;40(1):149\u201360. \n                    https:\/\/doi.org\/10.1002\/mus.21393\n                    \n                  .","DOI":"10.1002\/mus.21393"},{"key":"1054_CR22","first-page":"497","volume":"54","author":"MA Barba-Romero","year":"2012","unstructured":"Barba-Romero MA, Barrot E, Bautista-Lorite J, Gutierrez-Rivas E, Illa I, Jimenez LM, Ley-Martos M, Lopez de Munain A, Pardo J, Pascual-Pascual SI, et al. Clinical guidelines for late-onset Pompe disease. Rev Neurol. 2012;54:497\u2013507.","journal-title":"Rev Neurol"}],"container-title":["Orphanet Journal of Rare Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-019-1054-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s13023-019-1054-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-019-1054-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,4,1]],"date-time":"2020-04-01T23:19:43Z","timestamp":1585783183000},"score":1,"resource":{"primary":{"URL":"https:\/\/ojrd.biomedcentral.com\/articles\/10.1186\/s13023-019-1054-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,4,3]]},"references-count":22,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["1054"],"URL":"https:\/\/doi.org\/10.1186\/s13023-019-1054-0","relation":{},"ISSN":["1750-1172"],"issn-type":[{"value":"1750-1172","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,4,3]]},"assertion":[{"value":"27 November 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 March 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 April 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Approval from a local institutional review board\/ethics committee was required for inclusion in the Registry. Patient participation is voluntary, and written informed consent is obtained from all participants.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors and Sanofi Genzyme declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"78"}}